NASDAQ:LBRX LB Pharmaceuticals Q3 2026 Earnings Results & Report $38.09 -2.76 (-6.76%) Closing price 11/5/2026 04:00 PM EasternExtended Trading$38.10 +0.01 (+0.04%) As of 04:04 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. LB Pharmaceuticals missed analyst earnings expectations in its Q3 2026 results, released November 5, 2026. The company reported EPS of -$1.79 versus the -$1.61 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateNovember 5, 2026TimeAfter Market ClosesConference Call4:00 PM ET LB Pharmaceuticals EPS ResultsActual EPS-$1.79Consensus EPS -$1.61Beat/MissMissed by -$0.18One Year Ago EPSN/AEPS Beat Rate1 of last 5 quartersLB Pharmaceuticals Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) LB Pharmaceuticals Q3 2026 Earnings FAQ Did LB Pharmaceuticals beat earnings estimates for Q3 2026? LB Pharmaceuticals (NASDAQ:LBRX) reported earnings of -$1.79 per share for Q3 2026, missing the consensus estimate of -$1.61. The report was announced on Thursday, November 5, 2026. LB Pharmaceuticals Earnings HeadlinesLB Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Corporate UpdateNovember 5 at 4:05 PM | globenewswire.comLB Pharmaceuticals (NASDAQ:LBRX) Stock Lifted to Sell by Wall Street ZenOctober 31, 2026 | americanbankingnews.comGOP wipe out … but here’s WORSE news for the marketA 3 trillion dollar crisis may be building beneath the surface of the stock market, retirement accounts, pensions, and even banks. Reuters reports alarm bells echoing 2007 subprime warnings, and bestselling author Dr. Martin Weiss says this one may already be underway. His free briefing outlines five steps investors are considering to help protect their portfolios. | Weiss Ratings (Ad)LB Pharmaceuticals Inc (LBRX)October 29, 2026 | finance.yahoo.comLB Pharmaceuticals to Participate in Upcoming Investor EventsOctober 15, 2026 | globenewswire.comLB Pharmaceuticals (LBRX) Stock Fair Value Rises As LB 102 Outlook ShiftsOctober 10, 2026 | finance.yahoo.comSee More LB Pharmaceuticals Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like LB Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LB Pharmaceuticals and other key companies, straight to your email. Email Address About LB PharmaceuticalsLB Pharmaceuticals (NASDAQ:LBRX), Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for neuropsychiatric disorders. The company’s lead product candidate, LB-102, is an investigational oral therapy being developed for schizophrenia and potentially other conditions involving serious disturbances in mood, thought and behavior. LB-102 is designed as a prodrug of amisulpride, an antipsychotic compound that has been approved in certain markets outside the United States but is not approved by the U.S. Food and Drug Administration. LB Pharmaceuticals is evaluating whether its formulation can provide an effective and differentiated treatment option for patients with schizophrenia while addressing limitations associated with existing antipsychotic medicines. The company’s activities primarily involve research, clinical development and regulatory preparation for its pipeline in the United States and other potential markets. LB Pharmaceuticals is headquartered in New York City and is led by Chief Executive Officer Mark A. Alvino.View LB Pharmaceuticals ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to WatchQualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a CatchUber's Profit Drop: A Speed Bump or Structural Shift?Boeing Has the Orders, the Cash Flow, and Insider Buyers, But What's Still Missing?Keurig Dr Pepper's Beverage Growth Raises a Tough Question About Its Coffee SplitAmazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?Datadog's Post-Earnings Sell-Off: A Buying Opportunity in Plain Sight? Upcoming Earnings Occidental Petroleum (11/9/2026)KKR & Co. Inc. (11/9/2026)Barrick Mining (11/9/2026)Constellation Energy (11/9/2026)Petroleo Brasileiro S.A.- Petrobras (11/10/2026)Transdigm Group (11/10/2026)Honda Motor (11/11/2026)Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
